Advertisement

Does a Heart Team Improve Clinical Outcomes?

Published:February 12, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.01.006
      Consultation by a Heart Team (HT) is a class I recommendation by the American College of Cardiology, American Heart Association, and the European Society of Cardiology for the management of patients with complex cardiac disease. Despite the class I recommendation, there is a paucity of data to support the role of an HT with only level C quality of evidence. This study was performed to follow patients who were referred for HT consultation and long-term outcomes in relation to whether the recommendation of the HT was followed or not. We performed a prospective analysis of our cohort of patients who underwent consultation by the HT. A total of 342 cases have been followed. Patient characteristics, referring physicians’ favored treatment, and key outcomes were followed. A total of 336 patients were reviewed; 70.4% were male patients with a median age of 66.3 years and an average EuroSCORE II score of 7.2%. A total of 79.9% of the discussions resulted in a unanimous decision. The recommendations made by the HT differed from those documented by the referring physician in 54% of cases. In conclusion, recommendations made by the HT were followed in 269 cases (83.8%). There was a significant reduction in cardiac death (6.3% vs 15.3%, p = 0.042), composite cardiac outcome (23.4% vs 51.9%, p ≤0.001), and hospital admissions (10.4% vs 36.5%, p ≤0.001) when recommendations were followed. There was no statistical difference between the 2 groups when looking at noncardiac death, stroke, ST-segment elevation myocardial infarction, non–ST-segment elevation myocardial infarction, dialysis, or an emergency room visit.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kesson EM
        • Allardice GM
        • George WD
        • Burns HJ
        • Morrison DS.
        Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.
        BMJ. 2012; 344: e2718
        • Neumann FJ
        • Sousa-Uva M
        • Ahlsson A
        • Alfonso F
        • Banning AP
        • Benedetto U
        • Byrne RA
        • Collet JP
        • Falk V
        • Head SJ
        • Jüni P
        • Kastrati A
        • Koller A
        • Kristensen SD
        • Niebauer J
        • Richter DJ
        • Seferović PM
        • Sibbing D
        • Stefanini GG
        • Windecker S
        • Yadav R
        • Zembala MO
        ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization [published correction appears in Eur Heart J 2019;40:3096].
        Eur Heart J. 2019; 40: 87-165
        • Fihn SD
        • Gardin JM
        • Abrams J
        • Berra K
        • Blankenship JC
        • Dallas AP
        • Douglas PS
        • Foody JM
        • Gerber TC
        • Hinderliter AL
        • King SB
        • Kligfield PD
        • Krumholz HM
        • Kwong RY
        • Lim MJ
        • Linderbaum JA
        • Mack MJ
        • Munger MA
        • Prager RL
        • Sabik JF
        • Shaw LJ
        • Sikkema JD
        • Smith CR
        • Smith SC
        • Spertus JA
        • Williams SV
        American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2012; 60: e44-e164
        • Otto CM
        • Nishimura RA
        • Bonow RO
        • Carabello BA
        • Erwin 3rd, JP
        • Gentile F
        • Jneid H
        • Krieger EV
        • Mack M
        • McLeod C
        • O'Gara PT
        • Rigolin VH
        • Sundt 3rd, TM
        • Thompson A
        • Toly C.
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint Committee on Clinical Practice guidelines.
        Circulation. 2021; 143: e72-e227
        • Rosenschein U
        • Nagler RM
        • Rofe A.
        The Heart Team approach to coronary revascularization—have we crossed the lines of evidence-based medicine?.
        Am J Cardiol. 2013; 112: 1516-1519
        • Croke JM
        • El-Sayed S.
        Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature.
        Curr Oncol. 2012; 19: e232-e238
        • Long J
        • Luckraz H
        • Thekkudan J
        • Maher A
        • Norell M.
        Heart Team discussion in managing patients with coronary artery disease: outcome and reproducibility.
        Interact Cardiovasc Thorac Surg. 2012; 14: 594-598
        • Yamasaki M
        • Abe K
        • Horikoshi R
        • Hoshino E
        • Yanagisawa H
        • Yoshino K
        • Misumi H
        • Mizuno A
        • Komiyama N.
        Enhanced outcomes for coronary artery disease obtained by a multidisciplinary Heart Team approach.
        Gen Thorac Cardiovasc Surg. 2019; 67: 841-848
        • Patterson T
        • McConkey HZR
        • Ahmed-Jushuf F
        • Moschonas K
        • Nguyen H
        • Karamasis GV
        • Perera D
        • Clapp BR
        • Roxburgh J
        • Blauth C
        • Young CP
        • Redwood SR
        • Pavlidis AN
        Long-term outcomes following Heart Team revascularization recommendations in complex coronary artery disease.
        J Am Heart Assoc. 2019; 8e011279
        • Tsang MB
        • Schwalm JD
        • Gandhi S
        • Sibbald MG
        • Gafni A
        • Mercuri M
        • Salehian O
        • Lamy A
        • Pericak D
        • Jolly S
        • Sheth T
        • Ainsworth C
        • Velianou J
        • Valettas N
        • Mehta S
        • Pinilla N
        • Yanagawa B
        • Zhang L
        • Chu V
        • Parry D
        • Whitlock R
        • Dyub A
        • Cybulsky I
        • Semelhago L
        • Ioannou K
        • Hameed A
        • Wright D
        • Mulji A
        • Darvish-Kazem S
        • Gupta N
        • Alshatti A
        • Natarajan MK.
        Comparison of Heart Team vs interventional cardiologist recommendations for the treatment of patients with multivessel coronary artery disease.
        JAMA Network Open. 2020; 3e2012749
        • Kezerle L
        • Yohanan E
        • Cohen A
        • Merkin M
        • Ishay Y
        • Weinstein JM
        • Cafri C.
        The impact of Heart Team discussion on decision making for coronary revascularization in patients with complex coronary artery disease.
        J Card Surg. 2020; 35: 2719-2724
        • Chu D
        • Anastacio MM
        • Mulukutla SR
        • Lee JS
        • Smith AJ
        • Marroquin OC
        • Sanchez CE
        • Morell VO
        • Cook CC
        • Lico SC
        • Wei LM
        • Badhwar V.
        Safety and efficacy of implementing a multidisciplinary Heart Team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study.
        JAMA Surg. 2014; 149: 1109-1112
        • Pavlidis AN
        • Perera D
        • Karamasis GV
        • Bapat V
        • Young C
        • Clapp BR
        • Blauth C
        • Roxburgh J
        • Thomas MR
        • Redwood SR.
        Implementation and consistency of Heart Team decision-making in complex coronary revascularisation.
        Int J Cardiol. 2016; 206: 37-41
        • Domingues CT
        • Milojevic M
        • Thuijs DJFM
        • van Mieghem NM
        • Daemen J
        • van Domburg RT
        • Kappetein AP
        • Head SJ.
        Heart Team decision making and long-term outcomes for 1000 consecutive cases of coronary artery disease.
        Interact Cardiovasc Thorac Surg. 2018; 28: 206-213
        • Mishra PK
        • Luckraz H
        • Aktuerk D
        • Thekkudan J
        • Mahboob S
        • Norell M.
        How does the 'Heart Team' decision get enacted for patients with coronary artery disease?.
        Heart Asia. 2014; 6: 31-33
        • Sanchez CE
        • Dota A
        • Badhwar V
        • Kliner D
        • Smith AJ
        • Chu D
        • Toma C
        • Wei L
        • Marroquin OC
        • Schindler J
        • Lee JS
        • Mulukutla SR.
        Revascularization Heart Team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease.
        Catheter Cardiovasc Interv. 2016; 88: E103-E112
        • Sanchez C
        • Badhwar V
        • Dota A
        • Schindler J
        • Chu D
        • Smith A
        • Lee J
        • Khandhar S
        • Toma C
        • Marroquin O
        • Schmidhofer M
        • Bhama J
        • Wei L
        • Scolieri S
        • Esper S
        • Lee A
        • Mulukutla S.
        Practical implementation of the coronary revascularization Heart Team.
        Circ Cardiovasc Qual Outcomes. 2013; 6: 598-603